INTRAVESICAL GEMCITABINE IN COMBINATION WITH MITOMYCIN C AS SALVAGE TREATMENT IN RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Cockerill, Patrick
Knoedler, John
Karnes, Robert
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.2874
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1784
引用
收藏
页码：E733 / E733
页数：1
相关论文
共 50 条
  • [41] Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer
    Homayoun Zargar
    Jonathan Aning
    Joseph Ischia
    Alan So
    Peter Black
    Nature Reviews Urology, 2014, 11 : 220 - 230
  • [42] Comparisons of Intravesical Treatments with Mitomycin C, Gemcitabine, and Docetaxel for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: Updated Systematic Review and Meta-Analysis
    Matloubieh, Jubin E.
    Hanelin, David
    Agalliu, Ilir
    CANCERS, 2024, 16 (24)
  • [43] REAL-WORLD EFFICACY OF ADJUVANT INTRAVESICAL GEMCITABINE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Abou, Chakra Mohamad
    Vignesh, Packiam T.
    Michael, O'Donnell A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S54 - S54
  • [44] Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer
    Chakra, Mohamad Abou
    Mcelree, Ian M.
    Packiam, Vignesh T.
    Mott, Sarah L.
    O'Donnell, Michael A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (09) : 289e13 - 289e21
  • [45] Analysis of tolerance and security of chemo hyperthermia with Mitomycin C for the treatment of non-muscle invasive bladder cancer
    Leon-Mata, Juan
    Luis Dominguez, Jose
    Palou Redorta, Joan
    Sousa Gonzalez, Daniel
    Alvarez Casal, Maria
    Sousa Escandon, Alejandro
    Pineiro Vazquez, Eva
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (04): : 426 - 437
  • [46] TULA in recurrent non-muscle invasive bladder cancer
    Sarkar, Somita
    Mayor, Nikhil
    Mostafid, Hugh
    TRENDS IN UROLOGY & MENS HEALTH, 2020, 11 (01) : 18 - 19
  • [47] Prediction for recurrent non-muscle invasive bladder cancer
    Li, Keqiang
    Raveendran, Aravind
    Xie, Guoqing
    Zhang, Yu
    Wu, Haofan
    Huang, Zhenlin
    Jia, Zhankui
    Yang, Jinjian
    CANCER BIOMARKERS, 2023, 38 (03) : 275 - 285
  • [48] Multi-institutional review of sequential intravesical gemcitabine and mitomycin C chemotherapy for non-muscle-invasive bladder cancer
    Lightfoot, Andrew J.
    Breyer, Benjamin N.
    Rosevear, Henry M.
    Konety, Badrinath
    O'Donnell, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [49] Intravesical combination therapies for non-muscle invasive bladder cancer: Recent advances and future directions
    Li, You
    Youssef, Shams F.
    Buanz, Asma B. M.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 926
  • [50] Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy
    Kassouf, Wassim
    Kamat, Ashish M.
    Zlotta, Alexander
    Bochner, Bernard H.
    Moore, Ronald
    So, Alan
    Izawa, Jonathan
    Rendon, Ricardo A.
    Lacombe, Louis
    Aprikian, Armen G.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2010, 4 (03): : 168 - 173
12345